EMEA (Europe, Middle East and Africa) Spine Biologics Market Report 2017

Published Date : 2017-04-07

Published By : Qy Research Groups

Category : Pharma & Healthcare

No. of Pages : 114

In this report, the EMEA Spine Biologics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Spine Biologics for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Spine Biologics market competition by top manufacturers/players, with Spine Biologics sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
Alphatec Spine
K2M
Exactech
Wright Medical Technology
X-Spine Systems
Nutech
Arthrex

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma
BMAC

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Spine Biologics for each application, including
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion

Table of Contents

EMEA (Europe, Middle East and Africa) Spine Biologics Market Report 2017
1 Spine Biologics Overview
1.1 Product Overview and Scope of Spine Biologics
1.2 Classification of Spine Biologics
1.2.1 EMEA Spine Biologics Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Spine Biologics Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Bone Graft
1.2.4 Bone Graft Substitute
1.2.5 Platelet Rich Plasma
1.2.6 BMAC
1.3 EMEA Spine Biologics Market by Application/End Users
1.3.1 EMEA Spine Biologics Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Anterior Cervical Discectomy and Fusion
1.3.3 Posterior Lumbar Interbody Fusion
1.4 EMEA Spine Biologics Market by Region
1.4.1 EMEA Spine Biologics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Spine Biologics (2012-2022)
1.5.1 EMEA Spine Biologics Sales and Growth Rate (2012-2022)
1.5.2 EMEA Spine Biologics Revenue and Growth Rate (2012-2022)

2 EMEA Spine Biologics Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Spine Biologics Market Competition by Players/Manufacturers
2.1.1 EMEA Spine Biologics Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Spine Biologics Revenue and Share by Players (2012-2017)
2.1.3 EMEA Spine Biologics Sale Price by Players (2012-2017)
2.2 EMEA Spine Biologics (Volume and Value) by Type/Product Category
2.2.1 EMEA Spine Biologics Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Spine Biologics Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Spine Biologics Sale Price by Type (2012-2017)
2.3 EMEA Spine Biologics (Volume) by Application
2.4 EMEA Spine Biologics (Volume and Value) by Region
2.4.1 EMEA Spine Biologics Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Spine Biologics Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Spine Biologics Sales Price by Region (2012-2017)

3 Europe Spine Biologics (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Spine Biologics Sales and Value (2012-2017)
3.1.1 Europe Spine Biologics Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Spine Biologics Revenue and Growth Rate (2012-2017)
3.2 Europe Spine Biologics Sales and Market Share by Type
3.3 Europe Spine Biologics Sales and Market Share by Application
3.4 Europe Spine Biologics Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Spine Biologics Sales Volume by Countries (2012-2017)
3.4.2 Europe Spine Biologics Revenue by Countries (2012-2017)
3.4.3 Germany Spine Biologics Sales and Growth Rate (2012-2017)
3.4.4 France Spine Biologics Sales and Growth Rate (2012-2017)
3.4.5 UK Spine Biologics Sales and Growth Rate (2012-2017)
3.4.6 Russia Spine Biologics Sales and Growth Rate (2012-2017)
3.4.7 Italy Spine Biologics Sales and Growth Rate (2012-2017)
3.4.8 Benelux Spine Biologics Sales and Growth Rate (2012-2017)

4 Middle East Spine Biologics (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Spine Biologics Sales and Value (2012-2017)
4.1.1 Middle East Spine Biologics Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Spine Biologics Revenue and Growth Rate (2012-2017)
4.2 Middle East Spine Biologics Sales and Market Share by Type
4.3 Middle East Spine Biologics Sales and Market Share by Application
4.4 Middle East Spine Biologics Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Spine Biologics Sales Volume by Countries (2012-2017)
4.4.2 Middle East Spine Biologics Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Spine Biologics Sales and Growth Rate (2012-2017)
4.4.4 Israel Spine Biologics Sales and Growth Rate (2012-2017)
4.4.5 UAE Spine Biologics Sales and Growth Rate (2012-2017)
4.4.6 Iran Spine Biologics Sales and Growth Rate (2012-2017)

5 Africa Spine Biologics (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Spine Biologics Sales and Value (2012-2017)
5.1.1 Africa Spine Biologics Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Spine Biologics Revenue and Growth Rate (2012-2017)
5.2 Africa Spine Biologics Sales and Market Share by Type
5.3 Africa Spine Biologics Sales and Market Share by Application
5.4 Africa Spine Biologics Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Spine Biologics Sales Volume by Countries (2012-2017)
5.4.2 Africa Spine Biologics Revenue by Countries (2012-2017)
5.4.3 South Africa Spine Biologics Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Spine Biologics Sales and Growth Rate (2012-2017)
5.4.5 Egypt Spine Biologics Sales and Growth Rate (2012-2017)
5.4.6 Algeria Spine Biologics Sales and Growth Rate (2012-2017)

6 EMEA Spine Biologics Manufacturers/Players Profiles and Sales Data
6.1 Medtronic
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Spine Biologics Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Medtronic Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Depuy Synthes
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Spine Biologics Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Depuy Synthes Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Stryker Corporation
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Spine Biologics Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Stryker Corporation Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Nuvasive
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Spine Biologics Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Nuvasive Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Zimmer Biomet
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Spine Biologics Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Zimmer Biomet Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Orthofix International
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Spine Biologics Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Orthofix International Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Globus Medical
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Spine Biologics Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Globus Medical Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Alphatec Spine
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Spine Biologics Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Alphatec Spine Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 K2M
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Spine Biologics Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 K2M Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Exactech
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Spine Biologics Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Exactech Spine Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Wright Medical Technology
6.12 X-Spine Systems
6.13 Nutech
6.14 Arthrex

7 Spine Biologics Manufacturing Cost Analysis
7.1 Spine Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Spine Biologics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Spine Biologics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Spine Biologics Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Spine Biologics Market Forecast (2017-2022)
11.1 EMEA Spine Biologics Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Spine Biologics Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Spine Biologics Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Spine Biologics Price and Trend Forecast (2017-2022)
11.2 EMEA Spine Biologics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Spine Biologics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Spine Biologics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Spine Biologics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Spine Biologics Sales Forecast by Type (2017-2022)
11.7 EMEA Spine Biologics Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Spine Biologics
Figure EMEA Spine Biologics Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Spine Biologics Sales Volume Market Share by Type (Product Category) in 2016
Figure Bone Graft Product Picture
Figure Bone Graft Substitute Product Picture
Figure Platelet Rich Plasma Product Picture
Figure BMAC Product Picture
Figure EMEA Spine Biologics Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Spine Biologics by Application in 2016
Figure Anterior Cervical Discectomy and Fusion Examples
Figure Posterior Lumbar Interbody Fusion Examples
Figure EMEA Spine Biologics Market Size (Million USD) by Region (2012-2022)
Figure Europe Spine Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Spine Biologics Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Spine Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Spine Biologics Revenue (Million USD) Status and Forecast by Countries
Figure Africa Spine Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Spine Biologics Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Spine Biologics Sales Volume and Growth Rate (2012-2022)
Figure EMEA Spine Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Spine Biologics Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Spine Biologics Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Spine Biologics Sales Share by Players (2012-2017)
Figure 2016 Spine Biologics Sales Share by Players
Figure 2017 Spine Biologics Sales Share by Players
Figure EMEA Spine Biologics Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Spine Biologics Revenue (Million USD) by Players (2012-2017)
Table EMEA Spine Biologics Revenue Share by Players (2012-2017)
Table 2016 EMEA Spine Biologics Revenue Share by Players
Table 2017 EMEA Spine Biologics Revenue Share by Players
Table EMEA Spine Biologics Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Spine Biologics Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Spine Biologics Sales Share by Type (2012-2017)
Figure Sales Market Share of Spine Biologics by Type (2012-2017)
Figure EMEA Spine Biologics Sales Market Share by Type (2012-2017)
Table EMEA Spine Biologics Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Spine Biologics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Spine Biologics by Type in 2016
Table EMEA Spine Biologics Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Spine Biologics Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Spine Biologics Sales Share by Application (2012-2017)
Figure Sales Market Share of Spine Biologics by Application (2012-2017)
Figure EMEA Spine Biologics Sales Market Share by Application in 2016
Table EMEA Spine Biologics Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Spine Biologics Sales Share by Region (2012-2017)
Figure Sales Market Share of Spine Biologics by Region (2012-2017)
Figure EMEA Spine Biologics Sales Market Share in 2016
Table EMEA Spine Biologics Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Spine Biologics Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Spine Biologics by Region (2012-2017)
Figure EMEA Spine Biologics Revenue Market Share Regions in 2016
Table EMEA Spine Biologics Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Spine Biologics Revenue and Growth Rate (2012-2017)
Table Europe Spine Biologics Sales (K MT) by Type (2012-2017)
Table Europe Spine Biologics Market Share by Type (2012-2017)
Figure Europe Spine Biologics Market Share by Type in 2016
Table Europe Spine Biologics Sales (K MT) by Application (2012-2017)
Table Europe Spine Biologics Market Share by Application (2012-2017)
Figure Europe Spine Biologics Market Share by Application in 2016
Table Europe Spine Biologics Sales (K MT) by Countries (2012-2017)
Table Europe Spine Biologics Sales Market Share by Countries (2012-2017)
Figure Europe Spine Biologics Sales Market Share by Countries (2012-2017)
Figure Europe Spine Biologics Sales Market Share by Countries in 2016
Table Europe Spine Biologics Revenue (Million USD) by Countries (2012-2017)
Table Europe Spine Biologics Revenue Market Share by Countries (2012-2017)
Figure Europe Spine Biologics Revenue Market Share by Countries (2012-2017)
Figure Europe Spine Biologics Revenue Market Share by Countries in 2016
Figure Germany Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure France Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure UK Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Spine Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Spine Biologics Sales (K MT) by Type (2012-2017)
Table Middle East Spine Biologics Market Share by Type (2012-2017)
Figure Middle East Spine Biologics Market Share by Type (2012-2017)
Table Middle East Spine Biologics Sales (K MT) by Applications (2012-2017)
Table Middle East Spine Biologics Market Share by Applications (2012-2017)
Figure Middle East Spine Biologics Sales Market Share by Application in 2016
Table Middle East Spine Biologics Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Spine Biologics Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Spine Biologics Sales Volume Market Share by Countries in 2016
Table Middle East Spine Biologics Revenue (Million USD) by Countries (2012-2017)
Table Middle East Spine Biologics Revenue Market Share by Countries (2012-2017)
Figure Middle East Spine Biologics Revenue Market Share by Countries (2012-2017)
Figure Middle East Spine Biologics Revenue Market Share by Countries in 2016
Figure Saudi Arabia Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Spine Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Spine Biologics Sales (K MT) by Type (2012-2017)
Table Africa Spine Biologics Sales Market Share by Type (2012-2017)
Figure Africa Spine Biologics Sales Market Share by Type (2012-2017)
Figure Africa Spine Biologics Sales Market Share by Type in 2016
Table Africa Spine Biologics Sales (K MT) by Application (2012-2017)
Table Africa Spine Biologics Sales Market Share by Application (2012-2017)
Figure Africa Spine Biologics Sales Market Share by Application (2012-2017)
Table Africa Spine Biologics Sales Volume (K MT) by Countries (2012-2017)
Table Africa Spine Biologics Sales Market Share by Countries (2012-2017)
Figure Africa Spine Biologics Sales Market Share by Countries (2012-2017)
Figure Africa Spine Biologics Sales Market Share by Countries in 2016
Table Africa Spine Biologics Revenue (Million USD) by Countries (2012-2017)
Table Africa Spine Biologics Revenue Market Share by Countries (2012-2017)
Figure Africa Spine Biologics Revenue Market Share by Countries (2012-2017)
Figure Africa Spine Biologics Revenue Market Share by Countries in 2016
Figure South Africa Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Table Medtronic Spine Biologics Basic Information List
Table Medtronic Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Medtronic Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Medtronic Spine Biologics Sales Market Share in EMEA (2012-2017)
Figure Medtronic Spine Biologics Revenue Market Share in EMEA (2012-2017)
Table Depuy Synthes Spine Biologics Basic Information List
Table Depuy Synthes Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Depuy Synthes Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Depuy Synthes Spine Biologics Sales Market Share in EMEA (2012-2017)
Figure Depuy Synthes Spine Biologics Revenue Market Share in EMEA (2012-2017)
Table Stryker Corporation Spine Biologics Basic Information List
Table Stryker Corporation Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Stryker Corporation Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Stryker Corporation Spine Biologics Sales Market Share in EMEA (2012-2017)
Figure Stryker Corporation Spine Biologics Revenue Market Share in EMEA (2012-2017)
Table Nuvasive Spine Biologics Basic Information List
Table Nuvasive Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Nuvasive Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Nuvasive Spine Biologics Sales Market Share in EMEA (2012-2017)
Figure Nuvasive Spine Biologics Revenue Market Share in EMEA (2012-2017)
Table Zimmer Biomet Spine Biologics Basic Information List
Table Zimmer Biomet Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Zimmer Biomet Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Zimmer Biomet Spine Biologics Sales Market Share in EMEA (2012-2017)
Figure Zimmer Biomet Spine Biologics Revenue Market Share in EMEA (2012-2017)
Table Orthofix International Spine Biologics Basic Information List
Table Orthofix International Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Orthofix International Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Orthofix International Spine Biologics Sales Market Share in EMEA (2012-2017)
Figure Orthofix International Spine Biologics Revenue Market Share in EMEA (2012-2017)
Table Globus Medical Spine Biologics Basic Information List
Table Globus Medical Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Globus Medical Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Globus Medical Spine Biologics Sales Market Share in EMEA (2012-2017)
Figure Globus Medical Spine Biologics Revenue Market Share in EMEA (2012-2017)
Table Alphatec Spine Spine Biologics Basic Information List
Table Alphatec Spine Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Alphatec Spine Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Alphatec Spine Spine Biologics Sales Market Share in EMEA (2012-2017)
Figure Alphatec Spine Spine Biologics Revenue Market Share in EMEA (2012-2017)
Table K2M Spine Biologics Basic Information List
Table K2M Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure K2M Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure K2M Spine Biologics Sales Market Share in EMEA (2012-2017)
Figure K2M Spine Biologics Revenue Market Share in EMEA (2012-2017)
Table Exactech Spine Biologics Basic Information List
Table Exactech Spine Biologics Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Exactech Spine Biologics Sales (K MT) and Growth Rate (2012-2017)
Figure Exactech Spine Biologics Sales Market Share in EMEA (2012-2017)
Figure Exactech Spine Biologics Revenue Market Share in EMEA (2012-2017)
Table Wright Medical Technology Spine Biologics Basic Information List
Table X-Spine Systems Spine Biologics Basic Information List
Table Nutech Spine Biologics Basic Information List
Table Arthrex Spine Biologics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Spine Biologics
Figure Manufacturing Process Analysis of Spine Biologics
Figure Spine Biologics Industrial Chain Analysis
Table Raw Materials Sources of Spine Biologics Major Manufacturers in 2016
Table Major Buyers of Spine Biologics
Table Distributors/Traders List
Figure EMEA Spine Biologics Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Spine Biologics Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Spine Biologics Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Spine Biologics Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Spine Biologics Sales Market Share Forecast by Region (2017-2022)
Table EMEA Spine Biologics Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Spine Biologics Revenue Market Share Forecast by Region (2017-2022)
Table Europe Spine Biologics Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Spine Biologics Sales Market Share Forecast by Countries (2017-2022)
Table Europe Spine Biologics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Spine Biologics Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Spine Biologics Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Spine Biologics Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Spine Biologics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Spine Biologics Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Spine Biologics Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Spine Biologics Sales Market Share Forecast by Countries (2017-2022)
Table Africa Spine Biologics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Spine Biologics Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Spine Biologics Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Spine Biologics Sales Market Share Forecast by Type (2017-2022)
Table EMEA Spine Biologics Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Spine Biologics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-236-2744

sales@qyresearchgroups.com